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ABSTRACT

Obesity is the most common nutritional disorder in the United States and worldwide. Public
health efforts and other anti-obesity measures clearly have not controlled the obesity epidemic.
There is a great need to understand the pathogenic mechanisms underlying fat accumulation.
Research of the past decade supports a prominent role for diet-induced adipose tissue
dysfunction in the development and/or progression of obesity and associated insulin resistance.
Potential mechanisms for the development of adipose tissue dysfunction include ectopic
(visceral) fat accumulation, genetic factors, and alterations in autophagy and inflammatory
processes. However, the molecular mechanisms linking dietary fat intake with alterations in
adipose tissue autophagy levels are not well understood. A critical role of protein kinase C beta
(PKC) in obesity-associated adipose dysfunction is emerging. PKC deficiency protects from
high fat diet-induced obesity and related complications. High fat diet is also shown to induce
adipose PKC expression in mice, whereas PKC deficiency is reported to stimulate autophagy
in a cell culture model. Based on the above results, we hypothesized that high fat diet-induced
PKC activation in the adipose tissue inhibits autophagy and thereby promotes adipose
dysfunction and fat accumulation. We report here that high fat diet-induced adipose PKC
induction is accompanied by a simultaneous reduction in the ratio of autophagy markers LC3II/LC3-I protein expression in mice. Importantly, high fat diet was unable to alter this ratio in the
adipose tissue of PKC deficient mice. These results implicate PKC in mediating harmful
effects of high fat diet on adipose tissue autophagy levels. It is hoped that understanding the
PKC based pathogenic mechanisms leading to diet-induced adipose dysfunction will eventually
lead to novel therapeutic approaches to combat the obesity epidemic.
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ABBREVIATIONS USED

HFD, high-fat diet; LC3, microtubule-associated protein 1 light chain 3; PKC, protein kinase C
beta isoform; PKC-/-, protein kinase C-deficient mice; TG, triglycerides; WT, normal wildtype mice; WAT, white adipose tissue (visceral fat).
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INTRODUCTION

A. Obesity rates are rising in USA and worldwide:
The population of obese (defined as a body mass index of 30 or higher) individuals has increased
dramatically during recent decades (Fig. 1). In 1980, obese adults constituted roughly 15 percent
of the US population. By 2010, that number had risen to 36%, with roughly 69% the US
population considered overweight (defined as a body mass index between 25 and 29.9) or obese
(2). Most disturbing, is the fact that obesity rates have been steadily rising in children too.
Roughly 17% of children and teens are obese and 33% are considered overweight or obese (3).
As long as these trends continue, it has been predicted that about half of the US population will
be obese in 15 years (4).
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Obesity has become a worldwide phenomenon, now appearing in both developed and
undeveloped countries. Globally, nearly 10 percent of men and 14 percent of women (roughly
500 million adults) are estimated to be obese. Nearly three times as many are considered
overweight or obese (5, 6). There is less data available on global obesity rates in children, but a
recent global estimate found 43 million preschool children to be overweight or obese (7). If these
trends continue, over 1 billion adults are estimated to be obese in 15 years (8).
Obesity is a major contributor to the worldwide problem of chronic diseases. Abdominal
obesity in particular is suggested to play a central role in the development of obesity-related
illness, such as type 2 diabetes mellitus and cardiovascular diseases (9). Thus, it is unsurprising
that the incidence of obesity-associated disorders is also dramatically increasing and body fat and
weight gain over time are effective predictors of type 2 diabetes (11). While the relationship
between obesity, insulin resistance, and cardiovascular disease is well established (12), the
mechanisms underlying this relationship are still not well understood. It is estimated that the
total cost of treating obesity-related diseases in the US is roughly $180 billion (13).

B. Energy imbalance and obesity:
Obesity is defined as an abnormal or excessive fat accumulation resulting from an imbalance
between energy intake and energy expenditure. It is a complex polygenic disease that is caused
by a number of lifestyle and environmental factors including: genetics, sedentary lifestyle,
unhealthy diet, pregnancy, specific medications and sleep deficiency (15).
The combination of these factors results in a chronic positive energy imbalance, in which
energy intake is greater than energy expenditure for an extended period of time. It is generally
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believed that the development of obesity can be slowed down or avoided by modifying diet,
exercise, and behavior habits. Even though it is estimated that 40-70% of the variation in body
mass in a given population is a result of heritable factors (16, 17).

C. Adipose tissue dysfunction in obesity:
Adipose tissue is the most variable organ in mammals in terms of size. At the extremes in
humans, it ranges from a few percent of body weight in the malnourished to over 50% of total
weight in the morbidly obese (14). This excessive accumulation of fat in different depots is
associated with different metabolic consequences. Visceral fat creates a much greater risk of
developing diabetes than does subcutaneous or peripheral fat (18). In fact, fat accumulation in
the intra-abdominal visceral depot has been demonstrated to be an independent risk factor for the
development of cardiovascular diseases and type 2 diabetes (19). The insulin sensitivity of
visceral fat is different from that of subcutaneous adipose tissue (20). Lipids and other
metabolites from visceral adipose tissue can be drained directly into the liver via the portal vein.
Additionally, adipose and subcutaneous fat differ in their metabolism, gene expression and in
secretion of hormones called adipokines (16). They are cell signaling cytokines which
communicate with other tissues to modulate inflammation. Visceral adipose tissue
predominantly

secretes

many

pro-inflammatory

cytokines,

whereas

anti-inflammatory

adiponectin is highly expressed in subcutaneous fat (21).

D. Abnormal regulation of adipose tissue autophagy in obesity and diabetes:
Autophagy is responsible for the removal of malfunctioning organelles and misfolded
proteins via lysosomes (22). It is activated in response to stress and various physiological stimuli.
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Autophagy involves the formation of an autophagosome, a double-membrane cytoplasmic
vesicle that engulfs cellular components and fuses with lysosomes for degradation. The
formation of double-vesicle membrane is a complex process and involves more than 16 proteins.
A critical step in autophagy is the covalent lipidation of microtubule-associated protein 1 light
chain 3 (LC3) in which cleavage of LC3 allows a carboxy-terminal glycine to conjugate with
phospholipids. This process is required for the formation of autophagosomes. Migration of
lipidated LC3-II on SDS-PAGE gel monitors levels of autophagy at the cellular level. LC3-II
moves faster than LC3-I because of its association with the phosphatidylethanolamine group.
Commercial antibodies are available to measure expression of both LC3-I and LC3-II
simultaneously by immunoblotting. The above assay is generally used to measure cellular
autophagy levels due to lack of a direct method to visualize autophagy in animal tissue.
Autophagy is considered a cellular degradation pathway essential for survival (23). As a
protective mechanism, it safeguards organisms against normal and pathological conditions by
regulating the turnover of dysfunctional organelles and proteins. Increasing evidence suggests
that inhibition of autophagy greatly contributes to the accumulation of damaged organelles,
leading to cell dysfunction or death. There are specific mechanisms for degradation of particular
organelles; for example, mitochondria are degraded by autophagic mechanisms known as
mitophagy (25). The efficiency of this process has been shown to decline with aging, and which
can result in accumulation of damaged mitochondria (26, 27). The progressive decline of
mitochondrial function is considered a major mechanism underlying obesity (25, 27-31). It is
associated with less fatty acid oxidation and increased generation of reactive oxygen species,
with detrimental structural and functional consequences.
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Based on current knowledge, a model can be proposed to account for the development of
obesity in response to complex interactions between genes, environment, and behavior (Fig. 2).
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E. Established role of protein kinase Cbeta in diet-induced obesity and diabetes:
Protein kinase Cbeta (PKC), a member of the lipid-activated serine/threonine PKC
family, has recently been implicated as the master regulator of triglyceride homeostasis,
possibly via regulating mitochondrial function (32). PKC plays a critical role in mediating
deleterious effects of high-fat diet (HFD) on adipose functions: (i) HFD feeding of normal mice
for 12 weeks induces PKC protein expression in the white adipose tissue (WAT), but does
11

not affect expression in either liver or muscle (33), (ii) whole‐body deficiency of PKC leads
to leaner mice with significant reduction in body fat depots (32, 33) and these mice are resistant
to diet‐induced obesity and obesity‐related metabolic complications such as type 2 diabetes
(34), (iii) PKC‐/‐ adipocytes exhibit increased numbers of healthy mitochondria and higher
levels of fatty acid oxidation than WT (32); (iv) PKC levels are elevated in the adipose tissue
of leptin‐deficient ob/ob mice and PKC deficiency in these mice is also effective in reducing
obesity and diabetes (34); (v) weight gain related to treatment with antipsychotic drugs in
humans is linked to the activation of PKCexpression in adipose tissue (35); and (vi)
Polymorphism in the PKC gene is associated with development of Type 2 diabetes and related
complications (36, 37). The molecular mechanism underlying PKC action in the development
of obesity is not known but the potential role of autophagy is indicated by a recent study in
which overexpression of PKC in cultured cells (mouse embryo fibroblasts and human
embryonic kidney cells) negatively regulated autophagy by influencing mitochondrial
membrane potential (38). In view of relationships among reduced autophagy, increased
mitochondrial dysfunction and development of obesity (27-31, 39, 40), it will be interesting to
determine the role of PKC in regulating autophagy in the adipose tissue.
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HYPOTHESIS

Feeding mice a HFD for 12 weeks induces adipose PKC expression (32), whereas PKC
activation has been shown to inhibit autophagy in a cell culture system (34). Based on these
observations, we hypothesize that HFD-induced PKCβ activation in the white adipose
tissue (WAT) inhibits autophagy and thereby promotes adipose dysfunction and fat
accumulation in mice leading to the development of obesity (Fig. 3).

Fig. 3. Outline of proposed hypothesis and expected results. We propose that an increase in PKC
expression mediates HFD-induced suppression of autophagy in adipose tissue and accounts for its obesity
effects. We expect to see relationships among adipose PKC levels, suppression of autophagy and
accumulation of triglyceride levels in wild-type mice on HFD. In contrast, HFD is not expected to
suppress autophagy in the adipose tissue of PKC-/- mice.

To test the above hypothesis, we will examine the potential relationships among
diet‐induced changes in adipose PKC expression, autophagy and fat accumulation upon
feeding a HFD to WT and PKC-/- mice.
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MATERIALS AND METHODS

Animals and diet:
Generation of mice deficient in whole-body PKC expression (PKC-/-) has been previously
published (32-34). Six-week-old WT and PKC-/- male mice (n=6/genotype/diet group) were
fed ad libitum either a HFD (60% of calories derived from fat; diet TD.06414 from Harlan
Laboratories, IN) or a standard chow diet (17% of calories derived from fat; Harlan Tekland,
WI) for 16 weeks (41, 42). Mice were housed under controlled temperature (23oC) and lighting
(12 hours light/dark) with free access to water at the Ohio State University Animal Care Facility
located in the Biomedical Research Tower. All procedures on mice followed guidelines
established by the Ohio State University College of Medicine Animal Care Committee. At the
end of 16 weeks, mice were anesthetized and sacrificed. Body weight was measured for each
mouse. WAT (visceral fat depot) from the above animals was dissected out, weighed, and
immediately frozen in liquid nitrogen. The above procedures were carried out by lab
personnel.

Immunoblotting:
Frozen WAT (200 milligrams) samples was homogenized in lysis buffer (40 mM TrisHCl (pH 8.0), 150 mM NaCl, 0.5% sodium dodecyl sulfate, 0.5% sodium deoxycholate, 1%
Triton X‐100, phosphatase and protease inhibitors). Protein concentrations were determined
using a Pierce BCA protein assay kit (Life Technologies, CA). After adjusting the protein
concentration, equal amount of protein (30 g/lane for -Actin, 50 g/lane for PKC, and 100
g/lane for LC3s), along with colored molecular weight markers (BIO-RAD, CA), were
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subjected to electrophoresis in SDS-polyacrylamide gels. Proteins were transferred to
nitrocellulose membranes (BIO-RAD, CA) using a standard transfer buffer containing 20%
methanol. Membranes were blocked with Tris buffer containing 5% (w/v) non‐fat dried milk
for 1 hour. After washing with Tris buffer containg 500 mM NaCl and 0.05% (w/v) Tween
20, the membrane was probed with a primary PKCβ antibody (1:500 dilution; Santa Cruz
Biotechnology, CA) to visualize the kinetics of PKC (77 kDa) induction in the adipose tissue
of wild‐type mice, or probed with LC3-1 and LC3- 2
dilution; EMD Millipore, MA) to analyze the

(16/18 kDa) antibody (1:250

expression levels of LC3 type 1 and 2

proteins (as markers for autophagy levels) in the adipose tissues of WT and PKC‐/‐ mice,
or using -Actin (42 kDa) antibody (1:2000 dilution; Santa Cruz Biotechnology, CA). After
washing with buffer, the membranes were incubated with a secondary antibody conjugated to
horseradish peroxidase (1:5000 dilution) (BIO-RAD, CA) for 1 hour. Immunoreactive protein
bands were detected by using a SuperSignal substrate kit (Thermo Scientific Inc., IL).
Immunoreactive bands of predicted molecular mass were quantified with BioRad GS-800
calibrated densitometer using Quantify One analysis software (BIORAD, CA). Intensity of each
band was corrected for background differences and normalized to -actin loading control.

Statistical Analysis:
Experiments were performed in order to analyze all the groups of animals in parallel, n
representing the number of different individuals used in each group. Results are presented as
mean+SD of the number of samples indicated. Student’s t-test was used when the values of two
groups were analyzed. Data were considered statistically significant if P < 0.05.
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RESULTS
1. PKC-/- mice gain less weight compared to WT mice in response to feeding a HFD.
Both WT and PKC-/- mice were randomly divided into two groups. There were no significant
differences in the initial body weights of these mice (Supplementary Data). One group was fed a
chow diet and the other group was fed a HFD for 16 weeks, beginning at 6 weeks of age. At the
end of the feeding period, body weight and WAT weight were examined for each mouse in both
groups. It was observed that HFD feeding sharply increased body weights (43.58 ± 2.21 g WT
versus 31.58 ± 1.4 g PKC-/-, n=6, p<0.001) (Fig. 4) and WAT depot weights (2.43 ± 0.23 g
WT versus 0.76 ± 0.15 g PKC-/-, n=6, p<0.001) (Fig. 5 on next page) in WT mice compared to
PKC-/- mice.
Comparison of body size between
HFD-fed WT and PKC-/- mice

WT

PKC-/-

Fig. 4. PKC - / - mice are resistant to HFD-induced obesity compared to WT mice.
Comparison of body weights for WT and PKC - / - mice fed either a chow or HFD for
16 weeks is shown in the left panel.

Results are expressed as mean+SD. n=6, ***,

p<0.001. A representative picture of WT and PKC - / - mice fed HFD for 16 weeks is
shown in the right panel.
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Comparison of WAT size between
HFD-fed WT and PKC-/- mice

WT

PKC-/-

Fig. 5. HFD dramatically increases WAT depot weight in WT mice compared to
PKC - / - mice. Comparison of WAT weights for WT and PKC - / - mice fed either a
chow or HFD for 16 weeks is shown in the left panel. Results are expressed as
mean+SD. n=6, ***, p<0.001. A representative picture of WATs of HFD-fed WT and
PKC - / - mice is shown in the right panel.

2. HFD induces adipose PKC expression in mice. To determine PKC expression
in the above WT mice, we compared PKC protein levels in the WAT of these mice
after feeding either a chow or a HFD. It was observed that HFD feeding dramatically
increased PKC expression (>13-fold) in the WAT of WT mice (Fig. 6).
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Fig. 6. Effect of HFD feeding on adipose PKC expression. WT mice fed a chow or a HFD were
examined for proteins levels of PKC and -Actin (loading control) in the adipose tissue by
immunoblotting using an antibody to each protein. The quantitation of the immunoblot is shown in the
bottom panel. Each value represents the mean+SD. n=6, ***, p<0.001.

3.

HFD reduces autophagy in adipose tissue of WT, but not in PKC-/- mice. To

determine if the change in adipose PKC expression was associated with an alteration in
autophagy levels, we compared LC3 levels in the WATs obtained from WT mice fed a chow
or a HFD. Autophagy level was determined as the change of the amount of the
autophagosomal membrane marker LC3-II compared to LC3-I in vivo. This can serve as the
indicator of autophagy intensity. The relative ratio of LC3-II/LC3-I protein expression is
significantly reduced in the WAT of WT mice fed a HFD compared to WAT obtained from
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mice fed a chow diet (Fig. 7). Quantitation of changes in LC3-II/LC3-I levels (normalized to

-actin levels) indicated that the autophagy levels have been reduced by almost 59%. To
determine the effect of PKC deficiency on HFD-dependent suppression of autophagy levels,
we also compared the relative protein expression of LC3-I and LC3-II in the adipose tissues of
PKC-/- mice fed either a chow or HFD. Interestingly, feeding a HFD to PKC-/- mice had no
significant effect on the ratio of LC3-II/LC3-I protein expression and was found to be
comparable to mice fed a chow diet (Fig. 8).

Chow

HFD

18 kDa
16 kDa

LC3-I
LC3-II

42 kDa

-Actin

Fig. 7. Effect of HFD feeding on the relative protein expression of LC3-I and LC3-II in WT mice.
WT mice fed a chow or HFD were examined for LC3-I, LC3-II, and -Actin protein levels in the
adipose tissue by immunoblottting using an antibody to each protein. The quantitation of the
immunoblot is shown in the bottom panel. Each value represents the mean+SD. n=6, **, p<0.01.
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PKC-/- mice
Chow

HFD

18 kDa
16 kDa

LC3-I
LC3-II

42 kDa

-Actin

Fig. 8. Effect of HFD on relative protein expression of LC3-I and LC3-II in PKC-/- mice fed
either a chow or a HFD for 16 weeks. PKC-/- mice fed either a chow diet or a HFD were examined
for LC3-I, LC3-II, and -Actin protein levels in the adipose tissue by immunoblottting using an
antibody to each protein. Quantitation of immunoblot is shown in the bottom panel. Each value
represents the mean+SD. n=6, (p=0.55).
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DISCUSSION AND CONCLUSIONS

The results presented above highlight a novel role of PKC in regulating HFD-dependent
suppression of adipose autophagy levels. We show that HFD-induced adipose PKC activation
(Fig. 6) is accompanied by a simultaneous decrease in adipose autophagy levels in WT mice
(Fig. 7). Most importantly, HFD was unable to significantly affect adipose autophagy levels in
PKC-/- mice (Fig. 8), providing strong support for a novel role of PKC in regulating
autophagy levels in vivo. Our observation that HFD reduces adipose autophagy levels is in
agreement with recent reports that feeding HFD reduces autophagy and in WAT of WT mice,
but the underlying mechanism was not investigated in their studies (43, 44). A defect in
autophagic activity was also recently identified in liver tissues of insulin-resistant mice, and the
correction of autophagy by genetic means was sufficient to restore the hepatic responsiveness to
insulin, thus also supporting a strong link between defective autophagy and obesity-associated
insulin resistance (45). Given that PKC deficiency protects from diet-induced obesity and
diabetes (34), our results are also in agreement with the notion that defective regulation of
autophagy could be one of the mechanisms linking caloric overload to the development of
insulin resistance. It is important to note in this regard that common glucose-lowering
medications, including metformin and thiazolidinediones, have also been shown to stimulate
autophagy (46, 47). Lastly, an increase in autophagy has been recently shown to be required for
the beneficial effects of exercise on glucose and lipid metabolism (48).

Several lines of evidence implicate mitochondrial dysfunction as a major contributor to
obesity (27-31). It is likely that damaged mitochondria not only oxidize fat inefficiently, but
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also generate large amounts of reactive oxygen species which are known to disrupt cellular
function. Our results suggest that diet-dependent PKC activation contributes to a reduction
in autophagic activity, which can exacerbate the accumulation of harmful cellular “garbage”
including defective mitochondria. Failure to remove damaged mitochondria by a reduction in
“mitophagy” is expected to make adipocytes store extra calories as triglyceride more
efficiently (27-31, 39, 40).
Can a therapeutic strategy targeting adipose PKC be effective in treating dietary fat-induced
obesity and diabetes? Given that whole body PKC deficiency is associated with protection from
obesity possibly by increasing the percentage of healthy mitochondria in adipose tissue (25-27),
it is possible that PKC deficiency exerts this effect through promoting mitophagy. Thus
stimulating autophagy seems to be an attractive approach to improve adipose tissue adaptation to
the caloric load. Before such a possibility is considered further, an important question to be
answered is the specific contribution of adipose PKC deficiency to the lean phenotype of
PKC-/- mice. One approach to answering this question is by studying the sole contribution of
adipose-specific PKC deficiency to the lean phenotype of PKC-/- mice by generating tissuespecific mice using an inducible expression system (49, 50).
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